Amino Acid Analysis for MSUD Plasma Test

The Amino Acid Analysis for MSUD Plasma Test evaluates amino acid levels in plasma to aid in detecting and monitoring maple syrup urine disease. This inherited metabolic disorder is characterized by the body’s inability to properly break down branched-chain amino acids. By measuring leucine, isoleucine, and valine, the test identifies metabolic imbalances and provides valuable data for assessing disease progression and treatment response.

Specimen Type: Blood

Collection: Blood Draw

$179.95
Add to

The following is a list of what is included in the item above. Click the test(s) below to view what biomarkers are measured along with an explanation of what the biomarker is measuring.

Amino Acid Analysis for MSUD, LC/MS, Plasma #19779

6 Biomarkers - Specimen Type: Plasma-Unspecified Vial Pour - Collection Method: Phlebotomist - Process Time*: Average 7 to 8 business days

Also known as: Amino Acid Analysis for MSUD LCMS Plasma

Biomarkers 6

Alloisoleucine

Date Of Birth

Interpretation

Isoleucine

Leucine

Valine

*Important Information on Lab Test Processing Times: Ulta Lab Tests is committed to informing you about the processing times for your lab tests processed through a national lab. Please note that the estimated processing time for each test, indicated in business days, is based on data from the past 30 days across the 13 laboratories for each test. These estimates are intended to serve as a guide and are not guarantees. Factors such as laboratory workload, weather conditions, holidays, and the need for additional testing or maintenance can influence actual processing times. We aim to offer estimates to help you plan accordingly. Please understand that these times may vary, and processing times are not guaranteed. Thank you for choosing Ulta Lab Tests for your laboratory needs.

The Amino Acid Analysis for MSUD Plasma Test test contains 1 test with 6 biomarkers .

Amino acid analysis is necessary for the diagnosis of a variety of inborn errors of metabolism. These include, but are not limited to, phenylketonuria, tyrosimemia, citrullinemia, non-ketotic hyperglycinemia, maple syrup urine disease, and homocystinuria. The assay is also key for the continued monitoring of treatment plans for these disorders and useful for assessing nutritional status of patients. Our methodology is highly accurate at very low levels as well as at elevated levels.